O36.0933 Maternal care for other rhesus isoimmunization, third trimester, fetus 3

Name of the Condition

• Maternal care for other rhesus isoimmunization, third trimester, fetus 3
• ICD Code: O36.0933

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the third trimester who has developed antibodies against the Rh factor, excluding anti-D antibodies, with a focus on managing risks to the fetus. The care is specific to a pregnancy involving a third fetus when other Rh antibodies are present in late pregnancy.

Causes

Rhesus isoimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal blood, typically during a previous pregnancy or delivery. This exposure triggers the mother's immune system to produce antibodies that can cross the placenta and attack the red blood cells of an Rh-positive fetus in subsequent pregnancies. In this case, the antibodies are not anti-D but other Rh-specific antibodies.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., amniocentesis)
• Prior miscarriage or ectopic pregnancy involving an Rh-positive fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn

Diagnosis

Blood typing and antibody screening to detect non-anti-D Rh antibodies. Doppler ultrasound to assess fetal blood flow and anemia. Fetal blood sampling may be used to evaluate hemoglobin levels and confirm isoimmunization effects.

Treatment Options

• Close monitoring of fetal well-being through ultrasound and non-stress tests
• Administration of intravenous immunoglobulin (IVIG) to reduce antibody levels
• Intrauterine blood transfusions if fetal anemia is severe
• Early delivery planning if complications arise

Prognosis and Follow-Up

With proper monitoring and intervention, outcomes for both mother and fetus can be favorable. Follow-up includes continued fetal surveillance and postpartum monitoring of the newborn for signs of hemolysis or anemia. Long-term prognosis depends on the severity of fetal involvement and timely treatment.

Complications

• Severe fetal anemia leading to hydrops fetalis
• Preterm birth
• Neonatal jaundice requiring exchange transfusion
• Potential for neurological damage in the fetus if untreated

Lifestyle & Prevention

• Rh-negative women should receive Rh immunoglobulin (RhIg) after any potential sensitizing events, though this does not prevent non-anti-D isoimmunization
• Avoid unnecessary invasive procedures during pregnancy when possible
• Regular prenatal care to monitor antibody levels and fetal status

When to Seek Professional Help

Seek immediate medical attention if experiencing abdominal pain, vaginal bleeding, or reduced fetal movement. Regular prenatal visits are essential for monitoring, especially if previous sensitization is known.

Tips for Medical Coders

Document the trimester (third) and fetus number (3) clearly in the medical record. Ensure the presence of non-anti-D Rh antibodies is confirmed and linked to the maternal care provided. Code O36.0933 is specific to the third trimester and fetus 3; verify documentation supports these details to avoid miscoding.